首页> 外文期刊>The Journal of Urology >Defective Tamm-Horsfall protein in patients with interstitial cystitis.
【24h】

Defective Tamm-Horsfall protein in patients with interstitial cystitis.

机译:间质性膀胱炎患者的Tamm-Horsfall蛋白存在缺陷。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: Normal urinary Tamm-Horsfall protein shows a urothelial cytoprotective effect against potentially toxic compounds in urine that may injure the urothelium and cause bladder disease. One such disease is interstitial cystitis. In patients with interstitial cystitis this protective effect is decreased. We hypothesized that a difference in Tamm-Horsfall protein in patients with interstitial cystitis exists that may be involved in disease pathogenesis. MATERIALS AND METHODS: Using enzyme-linked immunosorbent assay the urinary Tamm-Horsfall protein concentration was determined in patients with interstitial cystitis and control subjects. Sialic acid content was measured by high performance liquid chromatography based assay. The structure of the protein glycosylation chains was analyzed using matrix assisted laser desorption/ionization-time of flight mass spectrometry. RESULTS: The mean Tamm-Horsfall protein concentration was not significantly different in patients with interstitial cystitis and controls (28.8 vs 28.2 mg/l urine and 36.8 vs 36.7 microg/mg creatinine, respectively, p = 0.6). The total mean sialic acid content of Tamm-Horsfall protein was almost 2-fold lower in 22 patients with interstitial cystitis compared with that in 20 controls (46.3 +/- 4.3 vs 75.3 +/- 4.1 nmol sialic acid per mg Tamm-Horsfall protein, respectively, p <0.0001). On matrix assisted laser desorption/ionization-time of flight mass spectrometry N-glycans released from Tamm-Horsfall protein revealed lower molecular weight di-antennary N-glycan structures and a resulting decrease in the number of terminal sialic acid residues in 10 patients with interstitial cystitis relative to those in 10 controls. CONCLUSIONS: Tamm-Horsfall protein is qualitatively different in patients with interstitial cystitis compared to controls. These data suggest that altered Tamm-Horsfall protein may be involved in interstitial cystitis pathogenesis and it may be useful for clinical diagnosis.
机译:目的:正常的尿液Tamm-Horsfall蛋白对尿液中的潜在毒性化合物具有尿路上皮细胞保护作用,这种化合物可能会损伤尿路上皮并引起膀胱疾病。一种这样的疾病是间质性膀胱炎。在间质性膀胱炎患者中,这种保护作用降低。我们假设间质性膀胱炎患者的Tamm-Horsfall蛋白存在差异,可能与疾病的发病机制有关。材料与方法:使用酶联免疫吸附法测定间质性膀胱炎患者和对照组的尿Tamm-Horsfall蛋白浓度。唾液酸含量通过基于高效液相色谱的测定法测量。使用基质辅助激光解吸/电离飞行时间质谱分析蛋白质糖基化链的结构。结果:间质性膀胱炎和对照组患者的Tamm-Horsfall蛋白平均浓度无显着差异(分别为28.8 vs 28.2 mg / l尿液和36.8 vs 36.7 microg / mg肌酐,p = 0.6)。 Tamm-Horsfall蛋白的总平均唾液酸含量与22名间质性膀胱炎患者的平均唾液酸含量相比20例降低了近2倍(每mg Tamm-Horsfall蛋白的46.3 +/- 4.3 vs 75.3 +/- 4.1 nmol唾液酸,分别为p <0.0001)。在基质辅助激光解吸/电离飞行时间质谱上,从Tamm-Horsfall蛋白释放的N-聚糖显示出较低的分子间双触角N-聚糖结构,并因此减少了10位间质性患者的末端唾液酸残基数量相对于10个对照组的膀胱炎。结论:与对照组相比,间质性膀胱炎患者的Tamm-Horsfall蛋白在质量上有差异。这些数据表明,改变的Tamm-Horsfall蛋白可能与间质性膀胱炎的发病机制有关,可能对临床诊断有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号